SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Antony Sguazzin
Retail
South Africa, the world’s second-largest exporter of oranges, lemons, and grapefruits, looks to peel back EU citrus restrictions it deems ‘not justified, proportionate or appropriate’
By
Antony Sguazzin
,
Paul Vecchiatto
, and others
China, Russia and their BRICS allies have a ‘medium to long term ambition’ to create a dollar rival as a currency, official says
By
Antony Sguazzin
and
Bloomberg
Environment
The owner of a giant ranch is auctioning off his 2,000 white rhinos after he failed to legalize selling horns
By
Antony Sguazzin
and
Bloomberg
Lifestyle
A De Beers rival is trying to revolutionize how giant diamonds worth millions of dollars are sold—and it’s working
By
Antony Sguazzin
and
Bloomberg
Health
Elton John advocates for global AIDS relief program that has saved millions of lives: ‘My dying wish is to have this disease eliminated by 2030’
By
Antony Sguazzin
and
Bloomberg
Health
New Omicron variants are so infectious that South Africa had a 5th wave even though 97% had antibody protection
By
Antony Sguazzin
and
Bloomberg
Health
Failure to address a global surplus of COVID vaccines raises the risk of new variants emerging, health experts warn
By
Josh Wingrove
,
James Paton
, and others
Health
Prior COVID infections and today’s vaccines likely won’t help you avoid the new Omicron variants, author of new study says
By
Antony Sguazzin
and
Bloomberg
Health
South African scientists have discovered 2 new Omicrons—and they’re already in Germany, Denmark and the U.K.
By
Antony Sguazzin
and
Bloomberg
Health
COVID-19 may have killed 1 of every 200 South Africans, 3 times the official rate
By
Antony Sguazzin
and
Bloomberg
Health
COVID boosters do not provide protection against Omicron, study finds
By
Antony Sguazzin
and
Bloomberg
Health
Omicron may cut future severity of COVID and protect against the Delta variant, South Africa study finds
By
Antony Sguazzin
and
Bloomberg
Health
Omicron causes less severe illness even in the unvaccinated, South Africa study says
By
Antony Sguazzin
and
Bloomberg
Health
Pfizer’s vaccine has a ‘robust, but not complete’ loss of immune protection against Omicron, tests show
By
Antony Sguazzin
,
Jason Gale
, and others
Health
South Africa could become COVID ‘mutation factory’ because of large HIV-infected population, scientists say
By
Rene Vollgraaff
,
Antony Sguazzin
, and others